Orthocell Appoints First Canadian Distributor for Nerve Repair Product Ahead of Official Launch; Shares Soar 13%

MT Newswires Live

Sep 30

Orthocell (ASX:OCC) appointed its first Canadian distributor for its nerve repair product Remplir ahead of an official in-country launch in early October, according to a Tuesday Australian bourse filing.

Approval processes for individual hospitals will be started immediately to facilitate the market entry, per the filing. Exclusive distributorships have been secured for Alberta and British Columbia, and further appointments are expected for other Canadian provinces.

The Canadian market launch will be overseen by the firm's existing in-house US-based marketing and medical education teams. Orthocell received a medical device license from Health Canada for the product in April.

The firm's shares jumped nearly 13% in recent trading on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2571398773"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571398773\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571398773?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 09:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571398773","market":"nz","top_or_hot":-1,"title":"Orthocell Appoints First Canadian Distributor for Nerve Repair Product Ahead of Official Launch; Shares Soar 13%","media":"MT Newswires Live","content":"<html><body><p> Orthocell (ASX:OCC) appointed its first Canadian distributor for its nerve repair product Remplir ahead of an official in-country launch in early October, according to a Tuesday Australian bourse filing.</p><p>Approval processes for individual hospitals will be started immediately to facilitate the market entry, per the filing. Exclusive distributorships have been secured for Alberta and British Columbia, and further appointments are expected for other Canadian provinces.</p><p>The Canadian market launch will be overseen by the firm's existing in-house US-based marketing and medical education teams. Orthocell received a medical device license from Health Canada for the product in April.</p><p>The firm's shares jumped nearly 13% in recent trading on Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orthocell Appoints First Canadian Distributor for Nerve Repair Product Ahead of Official Launch; Shares Soar 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrthocell Appoints First Canadian Distributor for Nerve Repair Product Ahead of Official Launch; Shares Soar 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-30 09:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Orthocell (ASX:OCC) appointed its first Canadian distributor for its nerve repair product Remplir ahead of an official in-country launch in early October, according to a Tuesday Australian bourse filing.</p><p>Approval processes for individual hospitals will be started immediately to facilitate the market entry, per the filing. Exclusive distributorships have been secured for Alberta and British Columbia, and further appointments are expected for other Canadian provinces.</p><p>The Canadian market launch will be overseen by the firm's existing in-house US-based marketing and medical education teams. Orthocell received a medical device license from Health Canada for the product in April.</p><p>The firm's shares jumped nearly 13% in recent trading on Tuesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCC.AU","symbol_name":"ORTHOCELL LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2571398773","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571398773","pubTimestamp":1759195901,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Orthocell  appointed its first Canadian distributor for its nerve repair product Remplir ahead of an official in-country launch in early October, according to a Tuesday Australian bourse filing.Approval processes for individual hospitals will be started immediately to facilitate the market entry, per the filing. Exclusive distributorships have been secured for Alberta and British Columbia, and further appointments are expected for other Canadian provinces.The Canadian market launch will be overseen by the firm's existing in-house US-based marketing and medical education teams. Orthocell received a medical device license from Health Canada for the product in April.The firm's shares jumped nearly 13% in recent trading on Tuesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCC.AU":"ORTHOCELL LTD","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"Orthocell在神经修复产品正式上市前指定了第一家加拿大经销商；股价飙升13%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCC.AU":1},"content_text":"Orthocell (ASX:OCC) appointed its first Canadian distributor for its nerve repair product Remplir ahead of an official in-country launch in early October, according to a Tuesday Australian bourse filing.Approval processes for individual hospitals will be started immediately to facilitate the market entry, per the filing. Exclusive distributorships have been secured for Alberta and British Columbia, and further appointments are expected for other Canadian provinces.The Canadian market launch will be overseen by the firm's existing in-house US-based marketing and medical education teams. Orthocell received a medical device license from Health Canada for the product in April.The firm's shares jumped nearly 13% in recent trading on Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}